 | • レポートコード：GIR-2104Z09882 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、神経バイオシミラー生物学的製剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。神経バイオシミラー生物学的製剤の種類別市場規模（注射、経口、局所、その他）、用途別市場規模（抗てんかん薬、神経因性疼痛、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・神経バイオシミラー生物学的製剤の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Axogen、Integra Biosciences AG、Synovis、Collagen Matrix、Polyganics、Checkpoint Surgical、Neurotex ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：注射、経口、局所、その他 ・用途別分析2016年-2026年：抗てんかん薬、神経因性疼痛、その他 ・神経バイオシミラー生物学的製剤の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・神経バイオシミラー生物学的製剤のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・神経バイオシミラー生物学的製剤のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・神経バイオシミラー生物学的製剤の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・神経バイオシミラー生物学的製剤の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Nerve Biosimilar Biological Products market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Nerve Biosimilar Biological Products size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Nerve Biosimilar Biological Products market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Nerve Biosimilar Biological Products market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Injection
Oral
Topical
Others
Market segment by Application can be divided into
Anti-Epileptic
Neuropathic Pain
Other
The key market players for global Nerve Biosimilar Biological Products market are listed below:
Axogen
Integra Biosciences AG
Synovis
Collagen Matrix
Polyganics
Checkpoint Surgical
Neurotex
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Nerve Biosimilar Biological Products Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Nerve Biosimilar Biological Products Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Injection
1.2.3 Oral
1.2.4 Topical
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Nerve Biosimilar Biological Products Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Anti-Epileptic
1.3.3 Neuropathic Pain
1.3.4 Other
1.4 Global Nerve Biosimilar Biological Products Market Size & Forecast
1.4.1 Global Nerve Biosimilar Biological Products Sales in Value (2016-2026))
1.4.2 Global Nerve Biosimilar Biological Products Sales in Volume (2016-2026)
1.4.3 Global Nerve Biosimilar Biological Products Price by Type (2016-2026) & (USD/Unit)
1.5 Global Nerve Biosimilar Biological Products Production Capacity Analysis
1.5.1 Global Nerve Biosimilar Biological Products Total Production Capacity (2016-2026)
1.5.2 Global Nerve Biosimilar Biological Products Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Nerve Biosimilar Biological Products Market Drivers
1.6.2 Nerve Biosimilar Biological Products Market Restraints
1.6.3 Nerve Biosimilar Biological Products Trends Analysis
2 Manufacturers Profiles
2.1 Axogen
2.1.1 Axogen Details
2.1.2 Axogen Major Business
2.1.3 Axogen Nerve Biosimilar Biological Products Product and Services
2.1.4 Axogen Nerve Biosimilar Biological Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Integra Biosciences AG
2.2.1 Integra Biosciences AG Details
2.2.2 Integra Biosciences AG Major Business
2.2.3 Integra Biosciences AG Nerve Biosimilar Biological Products Product and Services
2.2.4 Integra Biosciences AG Nerve Biosimilar Biological Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Synovis
2.3.1 Synovis Details
2.3.2 Synovis Major Business
2.3.3 Synovis Nerve Biosimilar Biological Products Product and Services
2.3.4 Synovis Nerve Biosimilar Biological Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Collagen Matrix
2.4.1 Collagen Matrix Details
2.4.2 Collagen Matrix Major Business
2.4.3 Collagen Matrix Nerve Biosimilar Biological Products Product and Services
2.4.4 Collagen Matrix Nerve Biosimilar Biological Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Polyganics
2.5.1 Polyganics Details
2.5.2 Polyganics Major Business
2.5.3 Polyganics Nerve Biosimilar Biological Products Product and Services
2.5.4 Polyganics Nerve Biosimilar Biological Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Checkpoint Surgical
2.6.1 Checkpoint Surgical Details
2.6.2 Checkpoint Surgical Major Business
2.6.3 Checkpoint Surgical Nerve Biosimilar Biological Products Product and Services
2.6.4 Checkpoint Surgical Nerve Biosimilar Biological Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Neurotex
2.7.1 Neurotex Details
2.7.2 Neurotex Major Business
2.7.3 Neurotex Nerve Biosimilar Biological Products Product and Services
2.7.4 Neurotex Nerve Biosimilar Biological Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Nerve Biosimilar Biological Products Sales by Manufacturer
3.1 Global Nerve Biosimilar Biological Products Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Nerve Biosimilar Biological Products Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Nerve Biosimilar Biological Products
3.4 Market Concentration Rate
3.4.1 Top 3 Nerve Biosimilar Biological Products Manufacturer Market Share
3.4.2 Top 6 Nerve Biosimilar Biological Products Manufacturer Market Share
3.5 Global Nerve Biosimilar Biological Products Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Nerve Biosimilar Biological Products Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Nerve Biosimilar Biological Products Market Size by Region
4.1.1 Global Nerve Biosimilar Biological Products Sales in Volume by Region (2016-2026)
4.1.2 Global Nerve Biosimilar Biological Products Revenue by Region (2016-2026)
4.2 North America Nerve Biosimilar Biological Products Revenue (2016-2026)
4.3 Europe Nerve Biosimilar Biological Products Revenue (2016-2026)
4.4 Asia-Pacific Nerve Biosimilar Biological Products Revenue (2016-2026)
4.5 South America Nerve Biosimilar Biological Products Revenue (2016-2026)
4.6 Middle East and Africa Nerve Biosimilar Biological Products Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Nerve Biosimilar Biological Products Sales in Volume by Type (2016-2026)
5.2 Global Nerve Biosimilar Biological Products Revenue by Type (2016-2026)
5.3 Global Nerve Biosimilar Biological Products Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Nerve Biosimilar Biological Products Sales in Volume by Application (2016-2026)
6.2 Global Nerve Biosimilar Biological Products Revenue by Application (2016-2026)
6.3 Global Nerve Biosimilar Biological Products Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Nerve Biosimilar Biological Products Sales by Type (2016-2026)
7.2 North America Nerve Biosimilar Biological Products Sales by Application (2016-2026)
7.3 North America Nerve Biosimilar Biological Products Market Size by Country
7.3.1 North America Nerve Biosimilar Biological Products Sales in Volume by Country (2016-2026)
7.3.2 North America Nerve Biosimilar Biological Products Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Nerve Biosimilar Biological Products Sales by Type (2016-2026)
8.2 Europe Nerve Biosimilar Biological Products Sales by Application (2016-2026)
8.3 Europe Nerve Biosimilar Biological Products Market Size by Country
8.3.1 Europe Nerve Biosimilar Biological Products Sales in Volume by Country (2016-2026)
8.3.2 Europe Nerve Biosimilar Biological Products Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Nerve Biosimilar Biological Products Sales by Type (2016-2026)
9.2 Asia-Pacific Nerve Biosimilar Biological Products Sales by Application (2016-2026)
9.3 Asia-Pacific Nerve Biosimilar Biological Products Market Size by Region
9.3.1 Asia-Pacific Nerve Biosimilar Biological Products Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Nerve Biosimilar Biological Products Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Nerve Biosimilar Biological Products Sales by Type (2016-2026)
10.2 South America Nerve Biosimilar Biological Products Sales by Application (2016-2026)
10.3 South America Nerve Biosimilar Biological Products Market Size by Country
10.3.1 South America Nerve Biosimilar Biological Products Sales in Volume by Country (2016-2026)
10.3.2 South America Nerve Biosimilar Biological Products Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Nerve Biosimilar Biological Products Sales by Type (2016-2026)
11.2 Middle East & Africa Nerve Biosimilar Biological Products Sales by Application (2016-2026)
11.3 Middle East & Africa Nerve Biosimilar Biological Products Market Size by Country
11.3.1 Middle East & Africa Nerve Biosimilar Biological Products Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Nerve Biosimilar Biological Products Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Nerve Biosimilar Biological Products Typical Distributors
12.3 Nerve Biosimilar Biological Products Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Nerve Biosimilar Biological Products Revenue by Type, (USD Million), 2021-2026
Table 2. Global Nerve Biosimilar Biological Products Revenue by Application, (USD Million), 2021-2026
Table 3. Axogen Basic Information, Manufacturing Base and Competitors
Table 4. Axogen Major Business
Table 5. Axogen Nerve Biosimilar Biological Products Product and Services
Table 6. Axogen Nerve Biosimilar Biological Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Integra Biosciences AG Basic Information, Manufacturing Base and Competitors
Table 8. Integra Biosciences AG Major Business
Table 9. Integra Biosciences AG Nerve Biosimilar Biological Products Product and Services
Table 10. Integra Biosciences AG Nerve Biosimilar Biological Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Synovis Basic Information, Manufacturing Base and Competitors
Table 12. Synovis Major Business
Table 13. Synovis Nerve Biosimilar Biological Products Product and Services
Table 14. Synovis Nerve Biosimilar Biological Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Collagen Matrix Basic Information, Manufacturing Base and Competitors
Table 16. Collagen Matrix Major Business
Table 17. Collagen Matrix Nerve Biosimilar Biological Products Product and Services
Table 18. Collagen Matrix Nerve Biosimilar Biological Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Polyganics Basic Information, Manufacturing Base and Competitors
Table 20. Polyganics Major Business
Table 21. Polyganics Nerve Biosimilar Biological Products Product and Services
Table 22. Polyganics Nerve Biosimilar Biological Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Checkpoint Surgical Basic Information, Manufacturing Base and Competitors
Table 24. Checkpoint Surgical Major Business
Table 25. Checkpoint Surgical Nerve Biosimilar Biological Products Product and Services
Table 26. Checkpoint Surgical Nerve Biosimilar Biological Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Neurotex Basic Information, Manufacturing Base and Competitors
Table 28. Neurotex Major Business
Table 29. Neurotex Nerve Biosimilar Biological Products Product and Services
Table 30. Neurotex Nerve Biosimilar Biological Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Global Nerve Biosimilar Biological Products Sales by Manufacturer (2019-2021e) & (K Units)
Table 32. Global Nerve Biosimilar Biological Products Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 33. Market Position of Manufacturers in Nerve Biosimilar Biological Products, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 34. Global Nerve Biosimilar Biological Products Production Capacity by Company, (K Units): 2020 VS 2021
Table 35. Head Office and Nerve Biosimilar Biological Products Production Site of Key Manufacturer
Table 36. Global Nerve Biosimilar Biological Products Sales by Region (2016-2021e) & (K Units)
Table 37. Global Nerve Biosimilar Biological Products Sales by Region (2021-2026) & (K Units)
Table 38. Global Nerve Biosimilar Biological Products Revenue by Region (2016-2021e) & (USD Million)
Table 39. Global Nerve Biosimilar Biological Products Revenue by Region (2021-2026) & (USD Million)
Table 40. Global Nerve Biosimilar Biological Products Sales by Type (2016-2021e) & (K Units)
Table 41. Global Nerve Biosimilar Biological Products Sales by Type (2021-2026) & (K Units)
Table 42. Global Nerve Biosimilar Biological Products Revenue by Type (2016-2021e) & (USD Million)
Table 43. Global Nerve Biosimilar Biological Products Revenue by Type (2021-2026) & (USD Million)
Table 44. Global Nerve Biosimilar Biological Products Price by Type (2016-2021e) & (USD/Unit)
Table 45. Global Nerve Biosimilar Biological Products Price by Type (2021-2026) & (USD/Unit)
Table 46. Global Nerve Biosimilar Biological Products Sales by Application (2016-2021e) & (K Units)
Table 47. Global Nerve Biosimilar Biological Products Sales by Application (2021-2026) & (K Units)
Table 48. Global Nerve Biosimilar Biological Products Revenue by Application (2016-2021e) & (USD Million)
Table 49. Global Nerve Biosimilar Biological Products Revenue by Application (2021-2026) & (USD Million)
Table 50. Global Nerve Biosimilar Biological Products Price by Application (2016-2021e) & (USD/Unit)
Table 51. Global Nerve Biosimilar Biological Products Price by Application (2021-2026) & (USD/Unit)
Table 52. North America Nerve Biosimilar Biological Products Sales by Country (2016-2021e) & (K Units)
Table 53. North America Nerve Biosimilar Biological Products Sales by Country (2021-2026) & (K Units)
Table 54. North America Nerve Biosimilar Biological Products Revenue by Country (2016-2021e) & (USD Million)
Table 55. North America Nerve Biosimilar Biological Products Revenue by Country (2021-2026) & (USD Million)
Table 56. North America Nerve Biosimilar Biological Products Sales by Type (2016-2021e) & (K Units)
Table 57. North America Nerve Biosimilar Biological Products Sales by Type (2021-2026) & (K Units)
Table 58. North America Nerve Biosimilar Biological Products Sales by Application (2016-2021e) & (K Units)
Table 59. North America Nerve Biosimilar Biological Products Sales by Application (2021-2026) & (K Units)
Table 60. Europe Nerve Biosimilar Biological Products Sales by Country (2016-2021e) & (K Units)
Table 61. Europe Nerve Biosimilar Biological Products Sales by Country (2021-2026) & (K Units)
Table 62. Europe Nerve Biosimilar Biological Products Revenue by Country (2016-2021e) & (USD Million)
Table 63. Europe Nerve Biosimilar Biological Products Revenue by Country (2021-2026) & (USD Million)
Table 64. Europe Nerve Biosimilar Biological Products Sales by Type (2016-2021e) & (K Units)
Table 65. Europe Nerve Biosimilar Biological Products Sales by Type (2021-2026) & (K Units)
Table 66. Europe Nerve Biosimilar Biological Products Sales by Application (2016-2021e) & (K Units)
Table 67. Europe Nerve Biosimilar Biological Products Sales by Application (2021-2026) & (K Units)
Table 68. Asia-Pacific Nerve Biosimilar Biological Products Sales by Region (2016-2021e) & (K Units)
Table 69. Asia-Pacific Nerve Biosimilar Biological Products Sales by Region (2021-2026) & (K Units)
Table 70. Asia-Pacific Nerve Biosimilar Biological Products Revenue by Region (2016-2021e) & (USD Million)
Table 71. Asia-Pacific Nerve Biosimilar Biological Products Revenue by Region (2021-2026) & (USD Million)
Table 72. Asia-Pacific Nerve Biosimilar Biological Products Sales by Type (2016-2021e) & (K Units)
Table 73. Asia-Pacific Nerve Biosimilar Biological Products Sales by Type (2021-2026) & (K Units)
Table 74. Asia-Pacific Nerve Biosimilar Biological Products Sales by Application (2016-2021e) & (K Units)
Table 75. Asia-Pacific Nerve Biosimilar Biological Products Sales by Application (2021-2026) & (K Units)
Table 76. South America Nerve Biosimilar Biological Products Sales by Country (2016-2021e) & (K Units)
Table 77. South America Nerve Biosimilar Biological Products Sales by Country (2021-2026) & (K Units)
Table 78. South America Nerve Biosimilar Biological Products Revenue by Country (2016-2021e) & (USD Million)
Table 79. South America Nerve Biosimilar Biological Products Revenue by Country (2021-2026) & (USD Million)
Table 80. South America Nerve Biosimilar Biological Products Sales by Type (2016-2021e) & (K Units)
Table 81. South America Nerve Biosimilar Biological Products Sales by Type (2021-2026) & (K Units)
Table 82. South America Nerve Biosimilar Biological Products Sales by Application (2016-2021e) & (K Units)
Table 83. South America Nerve Biosimilar Biological Products Sales by Application (2021-2026) & (K Units)
Table 84. Middle East & Africa Nerve Biosimilar Biological Products Sales by Country (2016-2021e) & (K Units)
Table 85. Middle East & Africa Nerve Biosimilar Biological Products Sales by Country (2021-2026) & (K Units)
Table 86. Middle East & Africa Nerve Biosimilar Biological Products Revenue by Country (2016-2021e) & (USD Million)
Table 87. Middle East & Africa Nerve Biosimilar Biological Products Revenue by Country (2021-2026) & (USD Million)
Table 88. Middle East & Africa Nerve Biosimilar Biological Products Sales by Type (2016-2021e) & (K Units)
Table 89. Middle East & Africa Nerve Biosimilar Biological Products Sales by Type (2021-2026) & (K Units)
Table 90. Middle East & Africa Nerve Biosimilar Biological Products Sales by Application (2016-2021e) & (K Units)
Table 91. Middle East & Africa Nerve Biosimilar Biological Products Sales by Application (2021-2026) & (K Units)
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Nerve Biosimilar Biological Products Typical Distributors
Table 95. Nerve Biosimilar Biological Products Typical Customers
List of Figures
Figure 1. Nerve Biosimilar Biological Products Picture
Figure 2. Global Nerve Biosimilar Biological Products Sales Market Share by Type in 2020
Figure 3. Injection
Figure 4. Oral
Figure 5. Topical
Figure 6. Others
Figure 7. Global Nerve Biosimilar Biological Products Sales Market Share by Application in 2020
Figure 8. Anti-Epileptic
Figure 9. Neuropathic Pain
Figure 10. Other
Figure 11. Global Nerve Biosimilar Biological Products Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 12. Global Nerve Biosimilar Biological Products Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. United States Nerve Biosimilar Biological Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Canada Nerve Biosimilar Biological Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Mexico Nerve Biosimilar Biological Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Germany Nerve Biosimilar Biological Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. France Nerve Biosimilar Biological Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. United Kingdom Nerve Biosimilar Biological Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Russia Nerve Biosimilar Biological Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Italy Nerve Biosimilar Biological Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. China Nerve Biosimilar Biological Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Japan Nerve Biosimilar Biological Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Korea Nerve Biosimilar Biological Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. India Nerve Biosimilar Biological Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Southeast Asia Nerve Biosimilar Biological Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Australia Nerve Biosimilar Biological Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Brazil Nerve Biosimilar Biological Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Egypt Nerve Biosimilar Biological Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Saudi Arabia Nerve Biosimilar Biological Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. South Africa Nerve Biosimilar Biological Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Turkey Nerve Biosimilar Biological Products Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Global Nerve Biosimilar Biological Products Sales (2016-2026) & (K Units)
Figure 33. Global Nerve Biosimilar Biological Products Production Capacity (2016-2026) & (K Units)
Figure 34. Global Nerve Biosimilar Biological Products Production Capacity by Geographic Region: 2020 VS 2021
Figure 35. Nerve Biosimilar Biological Products Market Drivers
Figure 36. Nerve Biosimilar Biological Products Market Restraints
Figure 37. Nerve Biosimilar Biological Products Market Trends
Figure 38. Global Nerve Biosimilar Biological Products Sales Market Share by Manufacturer in 2020
Figure 39. Global Nerve Biosimilar Biological Products Revenue Market Share by Manufacturer in 2020
Figure 40. Nerve Biosimilar Biological Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 41. Top 3 Nerve Biosimilar Biological Products Manufacturer (Revenue) Market Share in 2020
Figure 42. Top 6 Nerve Biosimilar Biological Products Manufacturer (Revenue) Market Share in 2020
Figure 43. Global Nerve Biosimilar Biological Products Sales Market Share by Region (2016-2026)
Figure 44. Global Nerve Biosimilar Biological Products Revenue Market Share by Region (2016-2026)
Figure 45. North America Nerve Biosimilar Biological Products Revenue (2016-2026) & (USD Million)
Figure 46. Europe Nerve Biosimilar Biological Products Revenue (2016-2026) & (USD Million)
Figure 47. Asia-Pacific Nerve Biosimilar Biological Products Revenue (2016-2026) & (USD Million)
Figure 48. South America Nerve Biosimilar Biological Products Revenue (2016-2026) & (USD Million)
Figure 49. Middle East & Africa Nerve Biosimilar Biological Products Revenue (2016-2026) & (USD Million)
Figure 50. Global Nerve Biosimilar Biological Products Sales Market Share by Type (2016-2026)
Figure 51. Global Nerve Biosimilar Biological Products Revenue Market Share by Type (2016-2026)
Figure 52. Global Nerve Biosimilar Biological Products Price by Type (2016-2026) & (USD/Unit)
Figure 53. Global Nerve Biosimilar Biological Products Sales Market Share by Application (2016-2026)
Figure 54. Global Nerve Biosimilar Biological Products Revenue Market Share by Application (2016-2026)
Figure 55. Global Nerve Biosimilar Biological Products Price by Application (2016-2026) & (USD/Unit)
Figure 56. North America Nerve Biosimilar Biological Products Sales Market Share by Country (2016-2026)
Figure 57. North America Nerve Biosimilar Biological Products Revenue Market Share by Country (2016-2026)
Figure 58. North America Nerve Biosimilar Biological Products Sales Market Share by Type (2016-2026)
Figure 59. North America Nerve Biosimilar Biological Products Sales Market Share by Application (2016-2026)
Figure 60. Europe Nerve Biosimilar Biological Products Sales Market Share by Country (2016-2026)
Figure 61. Europe Nerve Biosimilar Biological Products Revenue Market Share by Country (2016-2026)
Figure 62. Europe Nerve Biosimilar Biological Products Sales Market Share by Type (2016-2026)
Figure 63. Europe Nerve Biosimilar Biological Products Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Nerve Biosimilar Biological Products Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Nerve Biosimilar Biological Products Revenue Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Nerve Biosimilar Biological Products Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Nerve Biosimilar Biological Products Sales Market Share by Application (2016-2026)
Figure 68. South America Nerve Biosimilar Biological Products Sales Market Share by Country (2016-2026)
Figure 69. South America Nerve Biosimilar Biological Products Revenue Market Share by Country (2016-2026)
Figure 70. South America Nerve Biosimilar Biological Products Sales Market Share by Type (2016-2026)
Figure 71. South America Nerve Biosimilar Biological Products Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Nerve Biosimilar Biological Products Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Nerve Biosimilar Biological Products Revenue Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Nerve Biosimilar Biological Products Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Nerve Biosimilar Biological Products Sales Market Share by Application (2016-2026)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界の神経修復・再生用生物学的製剤市場 2021：企業別、地域別、種類・用途別 The Nerve Repair and Re-generation Biologic Products market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain op…- 世界のインフリキシマブ＆バイオシミラー市場 2021：企業別、地域別、種類・用途別 The Infliximab and Biosimilar market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…
- 世界のバイオシミラー試験・開発サービス市場規模・現状・予測（2021年-2027年） The global biosimilar testing and development services is segmented on the basis of clinical assays, comparability testing, and region. On the basis of clinical assays, it is divided into PK assay, tiered immunogenicity testing, and NAb assays. On the basis of comparability testing, it is classified…
- 世界のレミケードバイオシミラー市場 2021：企業別、地域別、種類・用途別 The Remicade Biosimilar market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…
- 世界のバイオシミラー市場 2021：企業別、地域別、種類・用途別 The Biosimilar market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent …